Yahoo Finance Today’s Research Reports on Trending Tickers: GW Pharmaceuticals and Arena Pharmaceuticals
NEW YORK, NY / ACCESSWIRE / April 18, 2018 / Markets continued to rise on Tuesday as investor focus continues to shift from geopolitical concerns to strong corporate earnings from major U.S. companies. The Dow Jones Industrial Average rose 0.87 percent to close at 24,786.63, while the S&P 500 Index jumped 1.07 percent to close 2,706.39, with all 11 S&P 500 sectors posting gains. The tech-heavy Nasdaq Composite Index spiked 1.74 percent to close at 7,281.10, as Netflix soared 9.19 percent on better-than-expected subscriber growth.
"Even though we this quarter had been marked by considerably high expectations, both earnings and revenue are coming in ahead of expectations. This is just what the doctor ordered to divert our attention from the uncertainty of geopolitical issues," said Mark Luschini, chief investment strategist at Janney Montgomery Scott, according to MarketWatch.
RDI Initiates Coverage on:
GW Pharmaceuticals Plc
https://rdinvesting.com/news/?ticker=GWPH
Arena Pharmaceuticals, Inc.
https://rdinvesting.com/news/?ticker=ARNA
GW Pharmaceuticals' stock jumped 11.24% Tuesday, to close the day at $134.13. The stock recorded a trading volume of 1,717,458 shares, which was above its three months average volume of 364,154 shares. In the last year, GW Pharmaceuticals' shares have traded in a range of 92.65 - 143.37. The share price has gained 44.77% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $115.92 is greater than its 200-day moving average of $120.92. Shares of GW Pharmaceuticals have gained roughly 12.89 percent in the past month and are up 1.61 percent year-to-date.
Access RDI's GW Pharmaceuticals Plc Research Report at:
https://rdinvesting.com/news/?ticker=GWPH
On Tuesday, shares of Arena Pharmaceuticals recorded a trading volume of 1,575,221 shares, which was above the three months average volume of 1,308,467 shares. The stock ended the day 7.96% higher at 37.03. The share price has gained 227.70% from its 52 week low with a 52 week trading range of 11.30 - 45.85. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $38.34 is greater than its 200-day moving average of $33.72. Shares of Arena Pharmaceuticals have gained roughly 17.52 percent in the past month and are up 9.01 percent year-to-date.
Access RDI's Arena Pharmaceuticals, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=ARNA
Our Actionable Research on GW Pharmaceuticals Plc (NASDAQ :GWPH) and Arena Pharmaceuticals, Inc. (NASDAQ :ARNA) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: RDInvesting.com
